APA (7th ed.) Citation

Dan Su, Bin Wu, & Lizheng Shi. (2021). Cost-Effectiveness of Genomic Test-Directed Olaparib for Metastatic Castration-Resistant Prostate Cancer. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Dan Su, Bin Wu, and Lizheng Shi. Cost-Effectiveness of Genomic Test-Directed Olaparib for Metastatic Castration-Resistant Prostate Cancer. Frontiers Media S.A., 2021.

MLA (9th ed.) Citation

Dan Su, et al. Cost-Effectiveness of Genomic Test-Directed Olaparib for Metastatic Castration-Resistant Prostate Cancer. Frontiers Media S.A., 2021.